ACC/AHA Heart Failure Staging
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۰۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Stage A0–0
- Stage B1–1
- Stage C2–2
- Stage D3–3
The ACC/AHA Heart Failure Staging calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include risk factors. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Describes heart failure stages and provides stage-specific therapy recommendations, based on ACC/AHA/HFSA guidelines
Clinical Indication
The ACC/AHA Heart Failure Staging is indicated for bedside clinical practice to support Describes heart failure stages and provides stage-specific therapy recommendations, based on ACC/AHA/HFSA guidelines. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Based on ACC/AHA/HFSA 2022 guidelines.
Classification based on presence of risk factors, structural disease, symptoms, and severity
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| risk_factors | string | Yes | Presence of risk factors for heart failure |
| structural_disease | string | Yes | Evidence of structural heart disease or elevated biomarkers |
| current_symptoms | string | Yes | Current or previous symptoms of heart failure |
| advanced_symptoms | string | Yes | Severe symptoms refractory to optimized treatment |
| hospitalization_frequency | string | Yes | Recurrent hospitalizations for heart failure |
| ejection_fraction | float | No | Left ventricular ejection fraction (%)(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Stage A | At risk for heart failure |
| 1–1 | Stage B | Pre-heart failure |
| 2–2 | Stage C | Symptomatic heart failure |
| 3–3 | Stage D | Advanced heart failure |
Evidence-Based References (EBM)
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032.
- Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation. 2005;112(12):e154-235.